ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
87 hedge funds and large institutions have $107M invested in Antares Pharma, Inc. in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 33 reducing their positions, and 9 closing their positions.
Holders
87
Holders Change
+5
Holders Change %
+6.1%
% of All Funds
2.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
20
Reduced
33
Closed
9
Calls
$9K
Puts
$291K
Net Calls
-$282K
Net Calls Change
+$58K
Top Buyers
| 1 |
BC
1
Broadfin Capital
New York
|
$12.1M |
| 2 |
BFA
2
BlackRock Fund Advisors
San Francisco,
California
|
$8.34M |
| 3 |
DM
3
Deerfield Management
New York
|
$20.8M |
| 4 |
B
4
Baird
Milwaukee,
Wisconsin
|
$648K |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$10.2M |
